Search results
Results from the WOW.Com Content Network
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [6]
University of California, San Francisco (UCSF), Calico (company), Genentech, Hoffmann-La Roche Hal V. Barron (born 1962) is an American clinician-scientist and drug developer who served as president of research and development at GlaxoSmithKline from March 2018 [ 1 ] until 2022, when he resigned in order to join the cellular reprogramming ...
Robert "Bob" Swanson (1947–1999) was an American venture capitalist who co-founded Genentech in 1976 with Herbert Boyer. Genentech is one of the leading biotechnology companies in the world. He was CEO of Genentech from 1976 to 1990, and chairman from 1990 to 1996.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
In 1976 Genentech, the first genetic engineering company was founded by Herbert Boyer and Robert Swanson and a year later the company produced a human protein (somatostatin) in E.coli. Genentech announced the production of genetically engineered human insulin in 1978. [75] In 1980 the U.S. Supreme Court in the Diamond v.
Together with Steve McKnight and Robert Tjian, he founded Tularik in 1991, and was their president and CEO until Tularik was acquired by Amgen for $1.3 billion in 2004. [3] Goeddel earned his bachelor's degree in chemistry from the University of California, San Diego, and his PhD in biochemistry from the University of Colorado, Boulder.
Genencor is a biotechnology company based in Palo Alto, CA and a subsidiary of IFF. [1] Genencor is a producer of Industrial enzymes and low-priced bulk protein. The name Genencor originates with Genencor, Inc., the original joint venture between Genentech and Corning Incorporated, which was founded in 1982.
Exelixis was founded in 1994; the scientific founders were Spyridon Artavanis–Tsakonas, at Yale at that time, and Corey Goodman and Gerry Rubin who were then at the University of California, Berkeley. [9] George Scangos joined the company as CEO in 1996. [10]